American Well Corporation

NYSE:AMWL

Medical - Healthcare Information Services

Healthcare
$11.03 +2.82%

+$0.24 today

Market cap
$171.77M
Beta
1.70
P/E (TTM)
-1.6
EPS (TTM)
-$5.30
52W Low $3.71High $9.96

Volume 0.06M

Average 0.07M

AMWL Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

American Well CorporationNYSE: AMWL

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 16.59M shares rose 5.9% year over year, behind the +6.6% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 1.2% from the prior quarter. Over 3 fiscal years it compounded at +5.4% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +5.9% toward the trailing-twelve-month pace of +6.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
16.59M+1.2% QoQ
Last fiscal yearDec 2025
16.05M+7.0% YoY
LTMMar 2026
16.27M+6.6% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.9%——
1 year+7.0%——
3-year CAGR+5.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
16.05M USD
Year-over-year change
+7.0%
4-year CAGR
+6.0%

Weighted Avg Shares vs competitors

How AMWL compares with its peers on the latest reported figures

  • AMWL's LTM Mar 2026 weighted avg shares of 16.27M shares is the 7th highest of the 9 companies compared; the peer median is 45.72M shares.
  • Its year-over-year change of +6.6% is the 8th highest of 9, against a peer median of +46.4%.
  • Over three fiscal years its annual growth of +5.4% compares with a peer median of +45.6%.
AMWL Competitors Peer median
Weighted Avg Shares for AMWL and competitors
Company Period LTM YoY 3-year CAGR
ATYRaTyr Pharma, Inc.LTM Mar 202695.83M +20.8%+48.5%
GUTSFractyl Health, Inc. Common StockLTM Mar 202666.33M +37.1%+16.8%
BMEABiomea Fusion, Inc.LTM Mar 202656.46M +55.6%+21.3%
ALXOALX Oncology Holdings Inc.LTM Mar 202653.9M +2.3%+9.7%
CAMPCAMP4 Therapeutics CorporationLTM Mar 202637.54M +102.0%—
IMUXImmunic, Inc.LTM Mar 202619.58M +98.7%+69.8%
AMWLAmerican Well CorporationLTM Mar 202616.27M +6.6%+5.4%
DTILPrecision BioSciences, Inc.LTM Mar 202612.13M +61.6%+63.6%
EUDAEUDA Health Holdings LimitedLTM Jun 20262.15M +23.1%+45.6%
Peer median (excluding AMWL) 45.72M+46.4%+45.6%

Competitors are the stored peer set for AMWL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue252.79M277.19M259.05M254.36M249.33M
Cost of Revenue148.47M160.42M164.29M155.41M116.47M
Gross Profit104.32M116.77M94.76M98.95M132.86M
Gross Margin41.3%42.1%36.6%38.9%53.3%
Research & Development106.59M138.49M105.83M86.07M72.86M
Selling, General & Admin160.78M227.98M213.11M197.45M131.31M
Operating Expenses283.46M392.62M786.9M316.49M238.13M
Depreciation & Amortization16.09M26.17M31.51M32.98M33.96M
EBITDA(166.07M)(245.84M)(224.15M)(176.91M)(60.57M)
EBITDA Margin-65.7%-88.7%-86.5%-69.6%-24.3%
Operating Income(179.15M)(275.85M)(692.14M)(217.53M)(105.27M)
Operating Margin-70.9%-99.5%-267.2%-85.5%-42.2%
Interest Income120K6.12M19.42M10.76M3.8M
Interest Expense00000
Other Income / Expenses(3.01M)3.85M16.83M7.65M10.74M
Income Before Tax(182.16M)(272.01M)(675.31M)(209.89M)(94.53M)
Pre-Tax Margin-72.1%-98.1%-260.7%-82.5%-37.9%
Income Tax Expense(5.38M)64K3.86M2.75M434K
Net Income(176.33M)(270.43M)(675.16M)(208.14M)(95.7M)
Net Margin-69.8%-97.6%-260.6%-81.8%-38.4%
EPS (Basic)(13.88)(19.68)(47.50)(13.88)(5.96)
EPS (Diluted)(13.88)(19.68)(47.50)(13.88)(5.96)
Weighted Avg Shares12.7M13.71M14.21M15M16.05M
Weighted Avg Shares (Diluted)12.7M13.71M14.21M15M16.05M

American Well Corporation

NYSE:AMWL

Intrinsic Alpha fair value

Locked

Current Price

$11.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.